Abstract
Ethyl glucuronide (EtG), a minor metabolite of ethanol, is used as a marker of alcohol consumption in a variety of clinical and forensic settings. At present there are very few studies of UDP-glucuronosyltransferases (UGT), responsible for catalyzing EtG formation, and the possible effect of nutritional components, e.g. flavonoids, which are extensively glucuronidated, on EtG formation has not been addressed at all. The following incubation conditions were optimized with regard to previously published conditions: buffer, substrate concentration, and incubation time. Isolation of EtG from the incubation mixture was also optimized. Recombinant UGT enzymes (UGT1A1, 1A3, 1A4, 1A6, 1A9, 2B7, 2B10, 2B15) were screened for their activity towards ethanol, and kinetic data were then established for all enzymes. It was decided to study the effect of the flavonoids quercetin and kaempferol on glucuronidation of ethanol. Isolation was by solid-phase extraction (SPE) to minimize matrix effects. Analysis was performed by liquid chromatography–tandem mass spectrometry (LC–MS–MS), with EtG-d5 as the internal standard. SPE was vital to avoid severe ion suppression after direct injection of the incubation solution. EtG formation was observed for all enzymes under investigation; their kinetics followed the Michaelis–Menten model, meaning the maximum reaction rate achieved at saturating substrate concentrations (V max) and the substrate concentration at which the reaction rate is half of V max (Michaelis–Menten constant, K m) could be calculated. The highest rate of glucuronidation was observed with UGT1A9 and 2B7. After co-incubation with both flavonoids, formation of EtG was significantly reduced for all enzymes except for UGT2B15, whose activity did not seem to be affected. Results reveal that multiple UGT isoforms are capable of catalyzing glucuronidation of ethanol; nevertheless, the effect of UGT polymorphism on glucuronidation of ethanol needs further study. Formation of EtG is inhibited by the flavonoids under investigation. Obviously, nutritional components affect conversion of ethanol to EtG. This observation may serve as a partial explanation of its variable formation in man.
Similar content being viewed by others
References
Wurst FM, Kempter C, Metzger J, Seidl S, Alt A (2000) Ethyl glucuronide: a marker of recent alcohol consumption with clinical and forensic implications. Alcohol 20:111–116
Wurst FM, Metzger J (2002) The ethanol conjugate ethyl glucuronide is a useful marker of recent alcohol consumption. Alcohol Clin Exp Res 26:1114–1119
Neubauer O (1901) Über Glykuronsäurepaarung bei Stoffen der Fettreihe. Arch Exp Pathol Pharmakol 46:133–154
Dahl H, Stephanson N, Beck O, Helander A (2002) Comparison of urinary excretion characteristics of ethanol and ethyl glucuronide. J Anal Toxicol 26:201–204
Goll M, Schmitt G, Ganssmann B, Aderjan RE (2002) Excretion profiles of ethyl glucuronide in human urine after internal dilution. J Anal Toxicol 26:262–266
Jaakonmaki PI, Knox KL, Horning EC, Horning MG (1967) The characterization by gas-liquid chromatography of ethyll beta-D-glucosiduronic acid as a metabolite of ethanol in rat and man. Eur J Pharmacol 1:63–70
Schmitt G, Droenner P, Skopp G, Aderjan R (1997) Ethyl glucuronide concentration in serum of human volunteers, teetotalers, and suspected drinking drivers. J Forensic Sci 42:1099–1102
Musshoff F, Daldrup T (1998) Determination of biological markers for alcohol abuse. J Chromatogr B 713:245–264
Halter CC, Dresen S, Auwaerter V, Wurst FM, Weinmann W (2008) Kinetics in serum and urinary excretion of ethyl sulfate and ethyl glucuronide after medium dose ethanol intake. Int J Legal Med 122:123–128
Paul R, Kingston R, Tsanaclis L, Berry A, Guwy A (2008) Do drug users use less alcohol than non-drug users? A comparison of ethyl glucuronide concentrations in hair between the two groups in medico-legal cases. Forensic Sci Int 176:82–86
Strassburg CP, Kneip S, Topp J, Obermayer-Straub P, Barut A, Tukey RH, Manns MP (2000) Polymorphic gene regulation and interindividual variation of UDP-glucuronosyltransferase activity in human small intestine. J Biol Chem 275:36164–36171
Foti RS, Fisher MB (2005) Assessment of UDP-glucuronosyltransferase catalyzed formation of ethyl glucuronide in human liver microsomes and recombinant UGTs. Forensic Sci Int 153:109–116
Al Saabi A, Allorge D, Sauvage FL, Tournel G, Gaulier JM, Marquet P, Picard N (2013) Involvement of UDP-Glucuronosyltransferases UGT1A9 an UGT2B7 in Ethanol Glucuronidation, and Interactions with Common Drugs of Abuse. Drug Metab Dispos 41:568–574
Chen Y, Xie S, Chen S, Zeng S (2008) Glucuronidation of flavonoids by recombinant UGT1A3 and UGT1A9. Biochem Pharmacol 76:416–425
King CD, Green MD, Rios GR, Coffman BL, Owens IS, Bishop WP, Tephly TR (1996) The glucuronidation of exogenous and endogenous compounds by stably expressed rat and human UDP-glucuronosyltransferase 1.1. Arch Biochem Biophys 332:92–100
Dixon M (1953) The determination of enzyme inhibitor constants. Biochem J 55:161–170
Kitz R, Wilson I (1962) Esters of methanesulfonic acid as irreversible inhibitors of Acetylcholinesterase. J Biol Chem 237:3245–3249
Annesley TM (2003) Ion suppression in mass spectrometry. Clin Chem 49:1041–1044
King R, Bonifiglio R, Fernadez-Metzler C, Miller-Stein C, Olah T (2000) Mechanistic investigation of ionization suppression in electrospray ionization. J Am Soc Mass Spectrom 11:942–950
Lagerwerf FM, van Dongen WD, Steenvoorden RJJM, Honing M, Jonkman JHG (2000) Exploring the boundaries of bioanalytical quantitative LC-MS-MS. Trend Anal Chem 19:418–427
Stingl JC, Bartels H, Viviani R, Lehmann ML, Brockmöller J (2013) Relevance of UDP-glucuronosyltransferase polymorphism for drug dosing: A quantitative systematic review. Pharmacol Ther. doi:10.1016/j.pharmther.2013.09.002
Agarwal DP (2001) Genetic polymorphisms of alcohol metabolizing enzymes. Pathol Biol (Paris) 49:703–709
Hamitouche S, Poupon J, Dreano Y, Amet Y, Lucas D (2006) Ethanol oxidation into acetaldehyde by 16 recombinant human cytochrome P450 isoforms: role of CYP2C isoforms in human liver microsomes. Toxicol Lett 167:221–230
Venkatakrishnan K, Von Moltke LL, Greenblatt DJ (2001) Human drug metabolism and the cytochromes P450: application and relevance of in vitro models. J Clin Pharmacol 41:1149–1179
Zhou S, Chan SY, Cher Goh B, Chan E, Duan E, Huang M, McLeod HL (2005) Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs. Clin Pharmacokinet 44:279–304
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schwab, N., Skopp, G. Identification and preliminary characterization of UDP-glucuronosyltransferases catalyzing formation of ethyl glucuronide. Anal Bioanal Chem 406, 2325–2332 (2014). https://doi.org/10.1007/s00216-014-7675-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-014-7675-1